Brief: Vbl Therapeutics Announces Successful Completion Of Pre-Ind Meeting With FDA Regarding Proposed Clinical Development Of Vb-601

Notable Labs

08/09/2020 13:51

Sept 8 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF
PRE-IND
MEETING WITH FDA REGARDING PROPOSED CLINICAL DEVELOPMENT OF
VB-601
    * VASCULAR BIOGENICS LTD - ALIGNMENT WITH FDA ON PATH
FORWARD FOR
DEVELOPMENT OF VB-601
    * VASCULAR BIOGENICS LTD - BASED ON FDA'S FEEDBACK, VBL
PLANS TO
ADVANCE ITS IND-ENABLING ACTIVITIES FOR VB-601 AS PLANNED

Source text for Eikon:  ID:nGNX8Ngxb0 
Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))